The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims.
Links The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims. Gift TL, Owens CJSex Transm Dis. 2006 Oct;33(10 Suppl):S84-8. Links The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims. Gift TL, Owens CJ. Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. tgift@cdc.gov BACKGROUND: Epididymitis and orchitis (EO) are the primary sequelae of acute chlamydia and gonorrhea in men. Existing estimates of the cost per episode of epididymitis are over 10 years old or are based on limited data. OBJECTIVE: The objective of this study was to estimate direct medical costs of EO from insurance claims data. STUDY DESIGN: We used 1998 and 1999 insurance claims taken from a national database. We used International Classification of Diseases, 9th Revision codes to identify inpatient and outpatient claims for EO treatment. Prescription drug claims were identified with National Drug Codes. To capture episodes of EO that were most likely sequelae of sexually transmitted diseases, we categorized claims based on age at the time of the initial EO claim. RESULTS: The total cost per episode was US dollars 368 for males or =13 and or =41 years of age. The cost for both younger and older men was significantly different from men or =13 and .
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. tgift@cdc.gov
BACKGROUND: Epididymitis and orchitis (EO) are the primary sequelae of acute chlamydia and gonorrhea in men. Existing estimates of the cost per episode of epididymitis are over 10 years old or are based on limited data. OBJECTIVE: The objective of this study was to estimate direct medical costs of EO from insurance claims data. STUDY DESIGN: We used 1998 and 1999 insurance claims taken from a national database. We used International Classification of Diseases, 9th Revision codes to identify inpatient and outpatient claims for EO treatment. Prescription drug claims were identified with National Drug Codes. To capture episodes of EO that were most likely sequelae of sexually transmitted diseases, we categorized claims based on age at the time of the initial EO claim. RESULTS: The total cost per episode was US dollars 368 for males <13 years of age, US dollars 242 for those > or =13 and <41 years of age, and US dollars 291 for those > or =41 years of age. The cost for both younger and older men was significantly different from men > or =13 and <41 years of age. Inpatient claims were relatively rare, occurring in < or =1.2% of total episodes. CONCLUSION: The cost per episode we calculated was lower than previously published estimates and can be attributed to a lower rate of inpatient care than previously observed or estimated.
This abstract is being posted for educational purposes, as well as for comment and criticism, by the visitors to the Epididymitis Foundation website (www.EpididymitisFoundation.org). This abstract is representative of a larger article that is indexed on Medline.
Men's Health Web Ring
SurvivingProstateCancerWithoutSurgery.org
VasectomyFoundation.org
Prostatitis Foundation
( Prostatitis.org)
Disclaimer: Information provided on this web site is for educatonal purposes only. It is not a substitute for, nor can it replace advice from your own physician. The information on this site is not to be used for diagnosing or treating any health concerns that you may have. Testicular torsion, which is a medical emergency can be confused with epididymitis. You must see your own physician for diagnosis and treatment. Furthermore, the information on this site is never guaranteed to be 100% accurate or 100% up to date. All the side effects of mentioned treatments, drugs, surgeries, or therapies cannot always be listed or be known. Errors and omissions may occur in any essay. See a competent physician for your health care needs.
EpididymitisFoundation.org™ Established December 11, 2002
